Plaque Psoriasis ICD-10 (L40.0): Documentation and Coding Guidelines

Plaque psoriasis is the diagnosis dermatologists document most often, and it carries one specific ICD-10-CM diagnosis code: L40.0. That part is simple. What causes trouble, especially for coders newer to dermatology claims, is everything sitting around it: an arthropathy code family that lives in the wrong chapter by most people’s intuition, an “other psoriasis” code that gets misquoted online as containing a subcode it doesn’t have, and a persistent assumption that severity or duration should change which code gets billed. It doesn’t. This guide works through the plaque psoriasis ICD-10 code and the rest of the L40 family the way an experienced coder would explain it to someone still learning dermatology documentation.

The ICD-10 code for plaque psoriasis is L40.0

L40.0, titled psoriasis vulgaris in the ICD-10-CM tabular list, is the code for plaque psoriasis. It’s billable and specific, meaning it can stand alone on a claim without a more granular fifth or sixth character attached. The current edition took effect October 1, 2025, as part of the annual FY2026 update from the Centers for Medicare and Medicaid Services and the National Center for Health Statistics, and the code’s description hasn’t changed since ICD-10-CM was first implemented for HIPAA transactions on October 1, 2015.

The Latin name trips up a lot of students the first time they see it. Vulgaris means common, not vulgar in the everyday sense, and dermatology uses that convention elsewhere too (acne vulgaris is the same pattern). Plaque psoriasis and psoriasis vulgaris are the same diagnosis: raised, well-demarcated red patches covered in silvery scale, most often on the elbows, knees, scalp, and lower back. When a note says “plaque psoriasis” and a coder assigns L40.0, that’s a direct match, not an approximation.

One distinction worth flagging early: psoriasis and dermatitis are coded in entirely different categories (L40 versus L20 through L30), even though both produce inflamed, scaling skin and get confused in casual conversation. A note describing “psoriatic dermatitis” or ambiguous scaling without a clear psoriasis diagnosis can leave a coder genuinely uncertain whether L40.8 or a dermatitis code like L30.8 applies. When that happens, the safest move is querying the provider rather than guessing, since the two code families sit in different sections of the tabular list and aren’t interchangeable.

The full L40 psoriasis code range

L40 by itself is a category header, not a billable code. CMS requires a fourth character or more before a psoriasis diagnosis can go on a claim. Here’s the complete family as it stands in the 2026 edition:

Thirteen distinct codes sit under one category, and six of them describe joint disease rather than skin disease. That ratio surprises people who assume psoriasis coding is mostly about the rash.

L40.9 deserves a specific mention because it gets used more than it should. It’s the right code only when documentation genuinely doesn’t specify a type, not as a default when a coder hasn’t looked closely enough. If a chart mentions plaques, pustules, or joint symptoms anywhere in the note, one of the more specific codes almost always applies instead.

Coding chronic plaque psoriasis

There’s no separate code for chronic plaque psoriasis, and searching for one wastes time. L40.0 covers the diagnosis whether it was made last week or two decades ago. Psoriasis is, by its clinical definition, a long-lasting, relapsing disease, so “chronic” describes its natural course rather than a distinct billable entity.

Duration does matter in a different context: once psoriasis is no longer the active problem being managed and a provider is documenting it as background rather than treating a flare. That’s when a history code applies instead of L40.0, a distinction covered later in this guide, not a modifier attached to the plaque psoriasis code itself.

Why there’s no code for severe or moderate to severe plaque psoriasis

This is the question behind the most searches, and the honest answer is that ICD-10-CM doesn’t grade plaque psoriasis by severity. L40.0 applies whether a patient has two coin-sized plaques or psoriasis covering half their body. Severity lives in the clinical documentation and in scoring tools, not in the diagnosis code.

Dermatology relies on body surface area, or BSA, as its simplest severity measure, with a patient’s own palm standing in for roughly 1% of BSA. The National Psoriasis Foundation, on its own published guidance for primary care providers, classifies psoriasis affecting less than 3% BSA as mild, 3% to 10% as moderate, and anything above 10% as severe. The American Academy of Dermatology draws the moderate band differently, at 5% up to 10% BSA, according to a dermatologist survey published in the Journal of Dermatological Treatment, which means two respected organizations don’t fully agree on where mild ends. Clinical trials and payers often fall back on a simpler two-category system instead, sometimes called the rule of tens: mild if BSA, Psoriasis Area and Severity Index (PASI), and Dermatology Life Quality Index (DLQI) scores are all 10 or under, moderate-to-severe if any one of those exceeds 10, with no separate middle category at all. Other sources split PASI itself into three bands, treating a score under 5 as mild, 5 to 10 as moderate, and above 10 as severe, so even the scoring tools aren’t applied identically from one guideline to the next.

The National Psoriasis Foundation has also pushed back on BSA as the only measure that matters. Its position statement notes that patients who don’t respond adequately to topical treatment, or whose plaques sit on the face, scalp, palms, soles, nails, or genitals, should be treated as moderate-to-severe regardless of what percentage of skin is technically involved, because those sites carry an outsized effect on daily functioning. The organization estimates that nearly one in four people with psoriasis have moderate to severe disease. None of this changes the ICD-10-CM code. A coder’s job is to capture L40.0 and, where the chart supports it, note the BSA percentage or PASI score already documented; severity itself isn’t something the diagnosis code was built to carry.

Generalized plaque psoriasis is a different question than it looks

Searches for “generalized plaque psoriasis ICD-10” often land people on L40.1 by mistake, because L40.1 is titled generalized pustular psoriasis and the word “generalized” matches what they typed. It is not the appropriate code for extensive plaque psoriasis. Pustular psoriasis is a separate clinical entity: it produces pus-filled pustules rather than plaques, can escalate rapidly, and includes rare, serious presentations such as the acute generalized form the German dermatologist Leo von Zumbusch first described in 1910, plus impetigo herpetiformis, a pustular flare associated with pregnancy. Widespread plaque psoriasis, however much of the body it covers, is still L40.0. ICD-10-CM doesn’t split that code by extent, even though L40.1’s title makes it look that way at a glance.

Coding guttate, pustular, and inverse psoriasis correctly

Guttate psoriasis, the small, drop-shaped lesions that often follow a streptococcal throat infection, has its own dedicated code: L40.4. It isn’t a subtype of L40.0, and the two shouldn’t be used interchangeably even though both fall under the same broader disease.

Pustular disease splits across three codes depending on where it shows up. L40.1 covers the generalized form; L40.2 covers acrodermatitis continua, a rare pattern centered on the fingers and toes that can damage the nail bed; and L40.3 covers pustulosis palmaris et plantaris, limited to the palms and soles.

Inverse psoriasis, sometimes called flexural or intertriginous psoriasis because it develops in skin folds such as the armpits, groin, and under the breasts, is where a real misconception has spread online. A handful of lower-quality coding sites list “L40.83” as the code for inverse psoriasis. That code does not exist in the current ICD-10-CM code set. The correct code is L40.8, other psoriasis, and the official ICD-10-CM index lists flexural psoriasis directly under it. There’s no further breakdown into L40.81, L40.82, or L40.89. If a claim gets denied over L40.83 or an audit flags it, that mismatch with the actual code set is the reason.

Psoriatic arthritis and the L40.5 codes

Psoriatic arthritis sits in an unusual spot for a joint condition: it’s coded under L40.5, inside the psoriasis category in the skin and subcutaneous tissue chapter, rather than under the musculoskeletal chapter where most arthritis codes live. Coders who assign category M07 (enteropathic arthropathies) are often relying on outdated guidance or non-U.S. coding references. ICD-10-CM’s own instructional notes attach a Type 1 Excludes note to M07 that specifically rules out psoriatic arthropathy and points back to L40.5-. The two categories are not meant to be used for the same diagnosis.

Six subcodes cover the clinical variation:

• L40.50, unspecified, for a documented diagnosis without detail on which joints are involved
• L40.51, distal interphalangeal involvement, frequently paired with nail changes in the same fingers
• L40.52, arthritis mutilans, the rare and destructive form involving bone resorption
• L40.53, psoriatic spondylitis, spinal involvement that shouldn’t be confused with ankylosing spondylitis under category M45
• L40.54, juvenile psoriatic arthropathy, for onset before age sixteen
• L40.59, other psoriatic arthropathy, for presentations that don’t fit the more specific codes above

A rheumatology note reading “psoriasis, stable on adalimumab; psoriatic arthritis involving the DIP joints of both hands” supports two codes reported together: L40.0 for the skin disease and L40.51 for the joint involvement. One code doesn’t replace the other, since they describe two manifestations of the same underlying condition. L40.50 remains a valid choice when joint detail genuinely isn’t documented, but it’s worth using sparingly. It doesn’t support medical necessity for biologic therapy nearly as well as a more specific subcode does when the chart already contains the detail needed to justify one.

Scalp and nail involvement don’t get their own codes

Scalp psoriasis and psoriasis capitis are clinical descriptions, not separate ICD-10-CM entities. When a provider documents plaque disease on the scalp, the code is still L40.0; the location goes in the note, not into a different fourth character. Nail involvement works the same way. Pitting, ridging, and separation of the nail plate in a patient with known plaque psoriasis are still coded L40.0, unless the presentation specifically matches acrodermatitis continua, which does carry its own code, L40.2, because it’s a distinct pustular condition rather than a routine manifestation of plaque disease on the fingers. Dermatologists sometimes note that nail changes alone can push a case toward a moderate-to-severe classification clinically, even without much visible skin involvement elsewhere, but that classification affects treatment decisions rather than which diagnosis code appears on the claim.

Personal and family history of psoriasis

Two Z codes come into play once psoriasis is no longer the condition being actively treated at a given visit. Z87.2, personal history of diseases of the skin and subcutaneous tissue, lists psoriasis among its recognized synonyms and applies when a patient’s documented past diagnosis is relevant to current care without being treated that day. Z84.0, family history of diseases of the skin and subcutaneous tissue, covers a documented family history, including familial psoriasis specifically, and supports risk assessment rather than active treatment. Neither code is unique to psoriasis; both sit inside broader skin-disease history categories, which matters because a coder searching for a dedicated “personal history of psoriasis” code won’t find one under its own heading.

From one ICD-9 code to a family of thirteen

Coders who trained before October 2015 remember a simpler system. ICD-9-CM grouped psoriasis under category 696, with 696.0 covering psoriatic arthropathy and 696.1 functioning as the general psoriasis code for nearly everything else, from plaque disease to the pustular variants. When CMS mapped 696.1 forward under the General Equivalence Mappings, it pointed to six separate ICD-10-CM codes, L40.0 through L40.4 and L40.8, because one ICD-9 code had been standing in for conditions ICD-10-CM now treats as clinically distinct. The arthropathy code split further still, with 696.0 mapping approximately to L40.54 and L40.59, an imprecise match that says less about those two specific codes and more about why GEM crosswalks work as a starting point for research rather than a substitute for reading the current chart.

That expansion reflects the broader pattern of the ICD-9-to-ICD-10 transition: more codes, more required specificity, and more responsibility on the coder to read the documentation carefully instead of defaulting to whichever code sounds closest. For plaque psoriasis, ICD-10 coding comes down to one stable code, L40.0, sitting inside a family of related codes that only cause problems when someone assumes they’re interchangeable with it.